Publication Information

{'id': 'https://openalex.org/W2411472382', 'doi': None, 'title': 'Development of HDAC inhibitors', 'display_name': 'Development of HDAC inhibitors', 'publication_year': 2010, 'publication_date': '2010-09-01', 'ids': {'openalex': 'https://openalex.org/W2411472382', 'mag': '2411472382', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/20841929'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pubmed/20841929', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5090624750', 'display_name': 'Yoshihiro Sowa', 'orcid': 'https://orcid.org/0000-0002-7112-1630'}, 'institutions': [{'id': 'https://openalex.org/I40677808', 'display_name': 'Kyoto Prefectural University of Medicine', 'ror': 'https://ror.org/028vxwa22', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I40677808']}], 'countries': ['JP'], 'is_corresponding': True, 'raw_author_name': 'Yoshihiro Sowa', 'raw_affiliation_strings': ['Dept. of Molecular-Targeting Cancer Prevention, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan.'], 'affiliations': [{'raw_affiliation_string': 'Dept. of Molecular-Targeting Cancer Prevention, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan.', 'institution_ids': ['https://openalex.org/I40677808']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5090624750'], 'corresponding_institution_ids': ['https://openalex.org/I40677808'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.133, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.415111, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 64, 'max': 71}, 'biblio': {'volume': '37', 'issue': '9', 'first_page': '1665', 'last_page': '1668'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11736', 'display_name': 'Histone Deacetylase Inhibitors Research', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11736', 'display_name': 'Histone Deacetylase Inhibitors Research', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12534', 'display_name': 'Protein Degradation and Inhibitors', 'score': 0.9879, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10185', 'display_name': 'Lymphoma Diagnosis and Treatment', 'score': 0.9254, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/romidepsin', 'display_name': 'Romidepsin', 'score': 0.96802783}, {'id': 'https://openalex.org/keywords/vorinostat', 'display_name': 'Vorinostat', 'score': 0.91210127}, {'id': 'https://openalex.org/keywords/epigenetic-therapy', 'display_name': 'Epigenetic Therapy', 'score': 0.5620164}, {'id': 'https://openalex.org/keywords/panobinostat', 'display_name': 'Panobinostat', 'score': 0.47078818}, {'id': 'https://openalex.org/keywords/combination-therapy', 'display_name': 'Combination therapy', 'score': 0.41692162}, {'id': 'https://openalex.org/keywords/histone-deacetylase-inhibitor', 'display_name': 'Histone deacetylase inhibitor', 'score': 0.41344988}], 'concepts': [{'id': 'https://openalex.org/C2781462825', 'wikidata': 'https://www.wikidata.org/wiki/Q7363205', 'display_name': 'Romidepsin', 'level': 5, 'score': 0.96802783}, {'id': 'https://openalex.org/C2776262904', 'wikidata': 'https://www.wikidata.org/wiki/Q905901', 'display_name': 'Vorinostat', 'level': 5, 'score': 0.91210127}, {'id': 'https://openalex.org/C41091548', 'wikidata': 'https://www.wikidata.org/wiki/Q26939', 'display_name': 'Epigenetics', 'level': 3, 'score': 0.84953845}, {'id': 'https://openalex.org/C2778305200', 'wikidata': 'https://www.wikidata.org/wiki/Q174378', 'display_name': 'Histone deacetylase', 'level': 4, 'score': 0.77011025}, {'id': 'https://openalex.org/C2780737395', 'wikidata': 'https://www.wikidata.org/wiki/Q18353741', 'display_name': 'Epigenetic therapy', 'level': 5, 'score': 0.5620164}, {'id': 'https://openalex.org/C64927066', 'wikidata': 'https://www.wikidata.org/wiki/Q36293', 'display_name': 'Histone', 'level': 3, 'score': 0.5214045}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.5000987}, {'id': 'https://openalex.org/C2780225316', 'wikidata': 'https://www.wikidata.org/wiki/Q7131441', 'display_name': 'Panobinostat', 'level': 5, 'score': 0.47078818}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.445049}, {'id': 'https://openalex.org/C2776999253', 'wikidata': 'https://www.wikidata.org/wiki/Q1304270', 'display_name': 'Combination therapy', 'level': 2, 'score': 0.41692162}, {'id': 'https://openalex.org/C555283112', 'wikidata': 'https://www.wikidata.org/wiki/Q1637543', 'display_name': 'Carcinogenesis', 'level': 3, 'score': 0.41484654}, {'id': 'https://openalex.org/C2776202225', 'wikidata': 'https://www.wikidata.org/wiki/Q3569101', 'display_name': 'Histone deacetylase inhibitor', 'level': 5, 'score': 0.41344988}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.38946852}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.3695997}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.3574611}, {'id': 'https://openalex.org/C190727270', 'wikidata': 'https://www.wikidata.org/wiki/Q874745', 'display_name': 'DNA methylation', 'level': 4, 'score': 0.25107163}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.22232479}, {'id': 'https://openalex.org/C552990157', 'wikidata': 'https://www.wikidata.org/wiki/Q7430', 'display_name': 'DNA', 'level': 2, 'score': 0.18915719}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.10716203}, {'id': 'https://openalex.org/C150194340', 'wikidata': 'https://www.wikidata.org/wiki/Q26972', 'display_name': 'Gene expression', 'level': 3, 'score': 0.09484267}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D056572', 'descriptor_name': 'Histone Deacetylase Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014408', 'descriptor_name': 'Biomarkers, Tumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014408', 'descriptor_name': 'Biomarkers, Tumor', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D002986', 'descriptor_name': 'Clinical Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D044127', 'descriptor_name': 'Epigenesis, Genetic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015972', 'descriptor_name': 'Gene Expression Regulation, Neoplastic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D056572', 'descriptor_name': 'Histone Deacetylase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pubmed/20841929', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/20841929', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3032358638', 'https://openalex.org/W2967433427', 'https://openalex.org/W2903647801', 'https://openalex.org/W2739782982', 'https://openalex.org/W2739589736', 'https://openalex.org/W2601491802', 'https://openalex.org/W2553813565', 'https://openalex.org/W2475853404', 'https://openalex.org/W2134284348', 'https://openalex.org/W2118638880', 'https://openalex.org/W2092476693', 'https://openalex.org/W2083124842', 'https://openalex.org/W2049366800', 'https://openalex.org/W2027619236', 'https://openalex.org/W2014941193', 'https://openalex.org/W2014100181', 'https://openalex.org/W1998928889', 'https://openalex.org/W1973736602', 'https://openalex.org/W1528961926', 'https://openalex.org/W110431090'], 'abstract_inverted_index': {'In': [0], 'the': [1, 40, 60, 69, 102], 'mechanisms': [2], 'of': [3, 27, 51], 'carcinogenesis,': [4], 'it': [5, 96], 'is': [6, 97], 'becoming': [7], 'apparent': [8], 'that': [9], 'not': [10], 'only': [11, 74], 'genetic': [12], 'abnormalities': [13, 20], 'including': [14], 'DNA': [15], 'mutations,': [16], 'but': [17, 78], 'also': [18, 79], 'epigenetic': [19, 34, 41], 'are': [21, 43, 57, 83], 'heavily': [22], 'involved.': [23], 'Simultaneously,': [24], 'certain': [25], 'kinds': [26], 'compounds': [28, 77], 'indicated': [29], 'anti-tumor': [30], 'activity': [31], 'through': [32], 'their': [33], 'effects.': [35], 'Typical': [36], 'drugs,': [37], 'which': [38], 'have': [39], 'effects,': [42], 'histone': [44], 'deacetylase(HDAC)': [45], 'inhibitors.': [46], 'So': [47], 'far,': [48], 'two': [49, 76], 'types': [50], 'HDAC': [52, 81, 112], 'inhibitors,': [53, 113], 'vorinostat': [54], 'and': [55, 89, 105], 'romidepsin,': [56], 'approved': [58], 'by': [59], 'Food': [61], 'Drug': [62], 'Administration': [63], 'for': [64, 111], 'cutaneous': [65], 'T-cell': [66], 'lymphoma': [67], 'in': [68, 87], 'U.': [70], 'S.': [71], 'A.': [72], 'Not': [73], 'these': [75], 'many': [80], 'inhibitors': [82], 'under': [84], 'clinical': [85], 'trials': [86], 'monotherapy': [88], 'combination': [90, 107], 'therapy.': [91], 'For': [92], 'a': [93], 'better': [94], 'outcome,': [95], 'very': [98], 'important': [99], 'to': [100, 115], 'establish': [101], 'appropriate': [103, 106], 'biomarkers': [104], 'based': [108], 'on': [109], 'mode-of-action': [110], 'similar': [114], 'other': [116], 'molecular-target': [117], 'antitumor': [118], 'drugs.': [119]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2411472382', 'counts_by_year': [], 'updated_date': '2024-12-11T15:48:12.530481', 'created_date': '2016-06-24'}